D1 dopamine receptor activity is not altered by a mutation in the first intracellular loop

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1402, Issue 2, 1998, Pages 165-170

  Jin, Hui ^a,b   Nip, Sukan ^b   O'Dowd, Brian F ^a,b   George, Susan R ^a,b  

^a CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Adenylyl cyclase; Dopamine; Intracellular loop; Mutant; Receptor

Indexed keywords

DOPAMINE 1 RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; HORMONE RECEPTOR;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; CHO CELL; CONTROLLED STUDY; HUMAN; MUTATION; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN STRUCTURE; RECEPTOR BINDING; SITE DIRECTED MUTAGENESIS;

ADENYLATE CYCLASE; AMINO ACID SEQUENCE; ANIMALS; COS CELLS; DOPAMINE; HUMANS; LEUCINE; MOLECULAR SEQUENCE DATA; MUTAGENESIS, SITE-DIRECTED; MUTATION; RECEPTORS, DOPAMINE D1; RECEPTORS, PITUITARY HORMONE; RECOMBINANT PROTEINS; SEQUENCE ALIGNMENT; SERINE;

ANIMALIA; NICOTIANA TABACUM;

EID: 0032571419     PISSN: 01674889     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-4889(97)00159-6     Document Type: Article

References (16)

1. Rosenthal W., Antaramian A., Gilbert S., Birnbaumer M. Nephrogenic diabetes insipidus: a V2 receptor unable to stimulate adenylyl cyclase. J. Biol. Chem. 268:1993;13030-13033.
2. Dryja T.P., McGee T.L., Hahn L.B., Cowley G.S., Olsson J.E., Reichel E., Sandberg M.A., Berson E.L. Mutation within the rhodopsin gene in patients with autosomal dominant retinitis pigmentosa. N. Engl. J. Med. 323:1990;1302-1307.
3. Sung C.-H., Davenport C.M., Hennessey J.C., Maumenee L.H., Jacobsen S.G., Heckenlively J.R., Nowakowsky P., Fishman G., Gouras P., Nathans J. Rhodopsin mutations in autosomal dominant retinitis pigmentosa. Proc. Natl. Acad. Sci. USA. 88:1991;6481-6485.
4. Schipani E., Kruse K., Jupper H. A constitutively active mutant PTH-PTHrP receptor in Jansen-type metaphyseal chrondrodysplasia. Science. 268:1995;98-100.
5. Robbins L.S., Nadeau J.H., Johnson K.R., Kelly M.A., Roselli-Rehfuss L., Baack E., Mountjoy K.G., Cone R.D. Pigmentation phenotypes of variant extension locus alleles result from point mutations that alter MSH receptor function. Cell. 72:1993;827-834.
6. Jin H., Zastawny R., George S., O'Dowd B.F. Elimination of palmitoylation sites in the human dopamine D1 receptor does not affect receptor-G protein interaction. Eur. J. Pharmacol. 324:1997;109-116.
7. Johnson R., Salomon Y. Assay of adenylyl cyclase catalytic activity. Meth. Enzymol. 195:1991;3-21.
8. Strader C.D., Fong T.M., Toca M.R., Underwood D., Dixon R.A.F. Structure and function of G protein-coupled receptors. Annu. Rev. Biochem. 63:1994;101-132.
9. Kobilka B.K., MacGreger C., Daniel K., Kobilka T.S., Caron M.G., Lefkowitz R.J. Functional activity and regulation of human β2-adrenergic receptors expressed in Xenopus oocytes. J. Biol. Chem. 262:1987;15796-15802.
10. O'Dowd B.F., Hnatowich M., Regan J.W., Leader W.M., Caron M.G., Lefkowitz R.J. Site-directed mutagenesis of the cytoplasmic domains of the human β2-adrenergic receptor. J. Biol. Chem. 263:1988;15985-15992.
11. Chazenbalk G.D., Nagayama Y., Russo D., Wadsworth H.L., Rapoport B. Functional analysis of the cytoplasmic domains of the human thyrotropin receptor by site-directed mutagenesis. J. Biol. Chem. 265:1990;20970-20975.
12. Kosugi S., Mori T. The first intracellular loop of the thyrotropin receptor is important for phosphoinositol signaling but not for agonist-induced adenylate cyclase. FEBS Lett. 341:1994;162-166.
13. Min K.C., Zvyaga T.A., Cypess A.M., Sakmar T.P. Characterization of mutant rhodopsins responsible for autosomal dominant retinitis pigmentosa. J. Biol. Chem. 268:1993;9400-9404.
14. Hirata T., Kakizuka A., Ushikubi F., Fuse I., Okuma M., Narumiya S. Arg60 to Leu mutation of the human thromboxane A2 receptor in a dominantly inherited bleeding disorder. J. Clin. Invest. 94:1994;1662-1667.
15. Nabhan C., Xiong Y., Xie L.Y., Abou-Sambra A.B. The alternatively spliced type II corticotropin-releasing factor receptor, stably expressed in LLCPK-1 cells, is not well coupled to the G protein(s). Biochem. Biophys. Res. Commun. 212:1995;1015-1021.
16. Wu V., Yang M., McRoberts J.A., Ren J., Seensalu R., Zeng N., Dagrag M., Birnbaumer M., Walsh J.H. First intracellular loop of the human cholecystokinin-A receptor is essential for cyclic AMP signaling in transfected HEK-293 cells. J. Biol. Chem. 272:1997;9037-9042.